Tetraspanin CD151 Protects against Pulmonary Fibrosis by Maintaining Epithelial Integrity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a chronic pulmonary disorder of unknown etiology with few treatment options. Although tetraspanins are involved in various diseases, their roles in fibrosis have not been determined. OBJECTIVES: To investigate the role of tetraspanin CD151 in pulmonary fibrosis. METHODS: CD151 knockout (KO) mice were studied by histological, biochemical, and physiological analyses and compared with wild-type mice and CD9 KO mice. Further mechanistic analyses were performed in vitro, in vivo, and on samples from patients with IPF. MEASUREMENTS AND MAIN RESULTS: A microarray study identified an enrichment of genes involved in connective tissue disorders in the lungs of CD151 KO mice, but not in CD9 KO mice. Consistent with this, CD151 KO mice spontaneously exhibited age-related pulmonary fibrosis. Deletion of CD151 did not affect pulmonary fibroblast functions but instead degraded epithelial integrity via attenuated adhesion strength on the basement membrane; CD151-deleted alveolar epithelial cells exhibited increased α-SMA expression with activation of p-Smad2, leading to fibrotic changes in the lungs. This loss of epithelial integrity in CD151 KO lungs was further exacerbated by intratracheal bleomycin exposure, resulting in severe fibrosis with increased mortality. We also observed decreased numbers of CD151-positive alveolar epithelial cells in patients with IPF. CONCLUSIONS: CD151 is essential for normal function of alveolar epithelial cells; loss of CD151 causes pulmonary fibrosis as a result of epithelial disintegrity. Given that CD151 may protect against fibrosis, this protein represents a novel target for the treatment of fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Thomas, A. Q., Lane, K., Phillips, J., Prince, M., Markin, C., Speer, M., Schwartz, D. A., Gaddipati, R., Marney, A., Johnson, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200112-123oc · Cited by 641
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Wang, X. M., Zhang, Y., Kim, H. P., Zhou, Z., Feghali-Bostwick, C. A., Liu, F., Ifedigbo, E., Xu, X., Oury, T. D., Kaminski, N., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061536 · Cited by 397 · cited 1×
“To date, numerous transgenicmice overexpressing profibrogenic cytokines exhibit pulmonary fibrosis (25), whereas only a few molecules that play protective roles in pulmonary fibrosis have been identified in mouse models or in humans: SPC (47), caveolin-1 (49, 50), relaxin (51), and connexin (52).”
BackgroundLipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium
Saiga, H., Nishimura, J., Kuwata, H., Okuyama, M., Matsumoto, S., Sato, S., Matsumoto, M., Akira, S., Yoshikai, Y., Honda, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8521 · Cited by 133
Self-citationBlood pressure influences end-stage renal disease of Cd151 knockout mice
Sachs, N., Claessen, N., Aten, J., Kreft, M., Teske, G. J. D., Koeman, A., Zuurbier, C. J., Janssen, H., & Sonnenberg, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58878 · Cited by 79
Cited by
Martinez, F. J., Collard, H. R., Pardo, A., Raghu, G., Richeldi, L., Selman, M., Swigris, J. J., Taniguchi, H., & Wells, A. U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.74 · Cited by 1,388
Selman, M., & Pardo, A. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2221pp · Cited by 454
Tetraspanin proteins promote multiple cancer stages
Hemler, M. E. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3640 · Cited by 404
Self-citationQuantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis
Tian, Y., Li, H., Gao, Y., Liu, C., Qiu, T., Wu, H., Cao, M., Zhang, Y., Ding, H., Chen, J., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9226-4 · Cited by 74
Yanagi, S., Tsubouchi, H., Miura, A., Matsumoto, N., & Nakazato, M. (2015) · BioMed Research International · doi:10.1155/2015/573210 · Cited by 71
Metadata
- Authors
- Tsujino, K., Takeda, Y., Arai, T., Shintani, Y., Inagaki, R., Saiga, H., Iwasaki, T., Tetsumoto, S., Jin, Y., Ihara, S., Minami, T., Suzuki, M., Nagatomo, I., Inoue, K., Kida, H., Kijima, T., Ito, M., Kitaichi, M., Inoue, Y., Tachibana, I., Takeda, K., Okumura, M., Hemler, M. E., & Kumanogoh, A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-07-15
- Volume
- 186
- Issue
- 2
- Pages
- 170-180
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2049324168
- Cited by
- 49
- References
- 5
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tetraspanin CD151 Protects against Pulmonary Fibrosis by Maintaining Epithelial Integrity. https://app.cochat.ai/papers/10.1164/rccm.201201-0117oc
- The paper
- Tsujino, K., Takeda, Y., Arai, T., Shintani, Y., Inagaki, R., Saiga, H., Iwasaki, T., Tetsumoto, S., Jin, Y., Ihara, S., Minami, T., Suzuki, M., Nagatomo, I., Inoue, K., Kida, H., Kijima, T., Ito, M., Kitaichi, M., Inoue, Y., . . . Kumanogoh, A. (2012). Tetraspanin CD151 Protects against Pulmonary Fibrosis by Maintaining Epithelial Integrity. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201201-0117oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.